
Apogee Therapeutics
Develops advanced biologics for treating inflammatory and immune diseases like atopic dermatitis and asthma.
Market cap
$2.2b
Enterprise value
$1.7b
Share price
$36.62 APGE
Authorizing premium user...
Develops advanced biologics for treating inflammatory and immune diseases like atopic dermatitis and asthma.